EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 41 / No 4 (Avril 2025) Med Sci (Paris), 41 4 (2025) 346-354 References
Open Access
Issue
Med Sci (Paris)
Volume 41, Number 4, Avril 2025
Page(s) 346 - 354
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2025047
Published online 28 April 2025
  1. Ankavay M, Dubuisson J, Cocquerel L. Le virus de l’hépatite E: Un virus méconnu qui se dévoile. Med Sci (Paris) 2018 ; 34 : 1071–78. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  2. Lhomme S, Marion O, Abravanel F, et al. Clinical manifestations, pathogenesis and treatment of hepatitis E virus infections. J Clin Med 2020 ; 9 : 331. [CrossRef] [PubMed] [Google Scholar]
  3. Kamar N, Selves J, Mansuy J-M, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008 ; 358 : 811–17. [CrossRef] [PubMed] [Google Scholar]
  4. Pallerla SR, Harms D, Johne R, et al. Hepatitis E virus infection: circulation, molecular epidemiology, and impact on global health. Pathogens 2020 ; 9 : 856. [CrossRef] [PubMed] [Google Scholar]
  5. Khuroo MS. Hepatitis E and Pregnancy: An Unholy Alliance Unmasked from Kashmir, India. Viruses 2021 ; 13 : 1329. [CrossRef] [PubMed] [Google Scholar]
  6. Pavio N, Kooh P, Cadavez V, et al. Risk factors for sporadic hepatitis E infection: a systematic review and meta-analysis. Microb Risk Anal 2021 ; 17 : 100129. [Google Scholar]
  7. WHO. Hepatitis E - Fact sheets. 2023. [Google Scholar]
  8. Kang S, Chung E, Hong C, et al. Raising the case of hepatitis E: Report from the 2nd international HEV symposium. Vaccine 2024 ; 42 : 126398. [CrossRef] [PubMed] [Google Scholar]
  9. Li P, Liu J, Li Y, et al. The global epidemiology of hepatitis E virus infection: A systematic review and meta–analysis. Liver Int 2020 ; 40 : 1516–28. [CrossRef] [PubMed] [Google Scholar]
  10. Mansuy JM, Gallian P, Dimeglio C, et al. A nationwide survey of hepatitis E viral infection in French blood donors. Hepatology 2016 ; 63 : 1145–54. [CrossRef] [PubMed] [Google Scholar]
  11. Aspinall EJ, Couturier E, Faber M, et al. Hepatitis E virus infection in Europe: surveillance and descriptive epidemiology of confirmed cases, 2005 to 2015. Euro Surveill 2017 ; 22. [Google Scholar]
  12. Pavio N, Merbah T, Thébault A. Frequent hepatitis E virus contamination in food containing raw pork liver, France. Emerg Infect Dis 2014 ; 20 : 1925–27. [CrossRef] [PubMed] [Google Scholar]
  13. Lhomme S, Magne S, Perelle S, et al. Clustered Cases of Waterborne Hepatitis E Virus Infection, France. Viruses 2023 ; 15 : 1149. [CrossRef] [PubMed] [Google Scholar]
  14. Fenaux H, Chassaing M, Berger S, et al. Transmission of hepatitis E virus by water: An issue still pending in industrialized countries. Water Research 2019 ; 151 : 144–57. [CrossRef] [PubMed] [Google Scholar]
  15. Treagus S, Lowther J, Longdon B, et al. Metabarcoding of hepatitis e virus genotype 3 and norovirus gii from wastewater samples in england using nanopore sequencing. Food Environ Virol 2023 ; 15 : 292–306. [CrossRef] [PubMed] [Google Scholar]
  16. Pillonel J, Maugard C, Sommen C, et al. Risk of a blood donation contaminated with hepatitis E virus entering the blood supply before the implementation of universal RNA screening in France. Vox Sang 2022 ; 117 : 1411–14. [CrossRef] [PubMed] [Google Scholar]
  17. Casares-Jimenez M, Garcia-Garcia T, Suárez-Cárdenas JM, et al. Correlation of hepatitis E and rat hepatitis E viruses urban wastewater monitoring and clinical cases. Sci Total Environ 2024 ; 908 : 168203. [CrossRef] [PubMed] [Google Scholar]
  18. Sridhar S, Situ J, Cai J-P, et al. Multimodal investigation of rat hepatitis E virus antigenicity: Implications for infection, diagnostics, and vaccine efficacy. J Hepatol 2021 ; 74 : 1315–24. [CrossRef] [PubMed] [Google Scholar]
  19. Devhare PB, Desai S, Lole KS. Innate immune responses in human hepatocyte-derived cell lines alter genotype 1 hepatitis E virus replication efficiencies. Sci Rep 2016 ; 6 : 26827. [CrossRef] [PubMed] [Google Scholar]
  20. Lhomme S, Migueres M, Abravanel F, et al. Hepatitis E Virus: How It Escapes Host Innate Immunity. Vaccines 2020 ; 8 : 422. [CrossRef] [PubMed] [Google Scholar]
  21. Yin X, Li X, Ambardekar C, et al. Hepatitis E virus persists in the presence of a type III interferon response. PLoS Pathog 2017 ; 13 : e1006417. [CrossRef] [PubMed] [Google Scholar]
  22. Murata K, Kang J-H, Nagashima S, et al. IFN-λ3 as a host immune response in acute hepatitis E virus infection. Cytokine 2020 ; 125 : 154816. [CrossRef] [PubMed] [Google Scholar]
  23. Meyer L, Duquénois I, Gellenoncourt S, et al. Identification of interferon- stimulated genes with modulated expression during hepatitis E virus infection in pig liver tissues and human HepaRG cells. Front Immunol 2023 ; 14 : 1291186. [CrossRef] [PubMed] [Google Scholar]
  24. León-Janampa N, Caballero-Posadas I, Barc C, et al. A pig model of chronic hepatitis E displaying persistent viremia and a downregulation of innate immune responses in the liver. Hepatol Commun 2023 ; 7 : e0274. [PubMed] [Google Scholar]
  25. Moal V, Textoris J, Ben Amara A, et al. Chronic hepatitis E virus infection is specifically associated with an interferon-related transcriptional program. J Infect Dis 2013 ; 207 : 125–32. [CrossRef] [PubMed] [Google Scholar]
  26. Pingale KD, Kanade GD, Karpe YA. Hepatitis E virus polymerase binds to IFIT1 to protect the viral RNA from IFIT1-mediated translation inhibition. J Gen Virol 2019 ; 100 : 471–83. [CrossRef] [PubMed] [Google Scholar]
  27. Xu L, Wang W, Li Y, et al. RIG-I is a key antiviral interferon-stimulated gene against hepatitis E virus regardless of interferon production: Xu et al. Hepatology 2017 ; 65 : 1823–39. [CrossRef] [PubMed] [Google Scholar]
  28. Plümers R, Dreier J, Knabbe C, et al. Kinetics of hepatitis E virus infections in asymptomatic persons. Emerg Infect Dis 2024 ; 30. [Google Scholar]
  29. Huang S, Zhang X, Su Y, et al. Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2024 ; 403 : 813–23. [CrossRef] [PubMed] [Google Scholar]
  30. Kulkarni SP, Sharma M, Tripathy AS. Antibody and memory B cell responses in hepatitis E recovered individuals, 1-30 years post hepatitis E virus infection. Sci Rep 2019 ; 9 : 4090. [CrossRef] [PubMed] [Google Scholar]
  31. Zhang J, Zhang X-F, Zhou C, et al. Protection against hepatitis E virus infection by naturally acquired and vaccine-induced immunity. Clin Microbiol Infect 2014 ; 20 : 397–405. [Google Scholar]
  32. Brüggemann Y, Klöhn M, Todt D. The pivotal role of CD8+ T cells in hepatitis E virus infection. J Hepatol 2022 ; 77 : 909–11. [CrossRef] [PubMed] [Google Scholar]
  33. León-Janampa N, Boennec N, Le Tilly O, et al. Relevance of tacrolimus trough concentration and hepatitis E virus genetic changes in kidney transplant recipients with chronic hepatitis E. Kidney Int Rep 2024 ; 9 : 1333–42. [CrossRef] [PubMed] [Google Scholar]
  34. Kamar N, Garrouste C, Haagsma EB, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011 ; 140 : 1481–89. [CrossRef] [PubMed] [Google Scholar]
  35. Kumar A, Saraswat VA. Hepatitis E and acute-on-chronic liver failure. J Clin Exp Hepatol 2013 ; 3 : 225–30. [CrossRef] [PubMed] [Google Scholar]
  36. Wu J, Xiang Z, Zhu C, et al. Extrahepatic manifestations related to hepatitis E virus infection and their triggering mechanisms. J Infect 2021 ; 83 : 298–305. [CrossRef] [PubMed] [Google Scholar]
  37. Marion O, Lhomme S, Nayrac M, et al. Hepatitis E virus replication in human intestinal cells. Gut 2020 ; 69 : 901–10. [CrossRef] [PubMed] [Google Scholar]
  38. Ying D, He Q, Tian W, et al. Urine is a viral antigen reservoir in hepatitis E virus infection. Hepatology 2023 ; 77 : 1722. [CrossRef] [PubMed] [Google Scholar]
  39. Tian D, Li W, Heffron CL, et al. Hepatitis E virus infects brain microvascular endothelial cells, crosses the blood-brain barrier, and invades the central nervous system. Proc Natl Acad Sci U S A 2022 ; 119 : e2201862119. [CrossRef] [PubMed] [Google Scholar]
  40. Bose PD, Das BC, Hazam RK, et al. Evidence of extrahepatic replication of hepatitis E virus in human placenta. J Gen Virol 2014 ; 95 : 1266–71. [CrossRef] [PubMed] [Google Scholar]
  41. Geng Y, Zhao C, Huang W, et al. Detection and assessment of infectivity of hepatitis E virus in urine. J Hepatol 2016 ; 64 : 37–43. [CrossRef] [PubMed] [Google Scholar]
  42. Dalton HR, Kamar N, Baylis SA, et al. EASL Clinical practice guidelines on hepatitis E virus infection. J Hepatol 2018 ; 68 : 1256–71. [CrossRef] [PubMed] [Google Scholar]
  43. Gouilly J, Chen Q, Siewiera J, et al. Genotype specific pathogenicity of hepatitis E virus at the human maternal-fetal interface. Nat Commun 2018 ; 9 : 4748. [CrossRef] [PubMed] [Google Scholar]
  44. Yadav KK, Boley PA, Fritts Z, et al. Ectopic expression of genotype 1 hepatitis E virus ORF4 increases genotype 3 HEV viral replication in cell culture. Viruses 2021 ; 13 : 75. [CrossRef] [PubMed] [Google Scholar]
  45. Abravanel F, Pique J, Couturier E, et al. Acute hepatitis E in French patients and neurological manifestations. J Infect 2018 ; 77 : 220–26. [CrossRef] [PubMed] [Google Scholar]
  46. Schmitz J, Kracht J, Evert K, et al. Hepatitis E virus infection of transplanted kidneys. Am J Transplant 2024 ; 24 : 491–97. [CrossRef] [PubMed] [Google Scholar]
  47. Panic N, Mihajlovic S, Vujasinovic M, et al. Pancreatitis Associated with Viral Hepatitis: Systematic Review. J Clin Med 2020 ; 9 : 3309. [CrossRef] [PubMed] [Google Scholar]
  48. Rasizadeh R, Ebrahimi F, Zamani Kermanshahi A, et al. Viruses and thrombocytopenia. Heliyon 2024 ; 10 : e27844. [CrossRef] [PubMed] [Google Scholar]
  49. French Agency for Food, Environmental and Occupational Health & Safety. AVIS de l’Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail. n.d. [Google Scholar]
  50. WHO, Environment, Climate Change and Health (ECH), Water, Sanitation, Hygiene and Health (WSH). State of the world’s drinking water: An urgent call to action to accelerate progress on ensuring safe drinking water for all. 2022 : p. [Google Scholar]
  51. Li SW, Zhang J, Li YM, et al. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine 2005 ; 23 : 2893–01. [CrossRef] [PubMed] [Google Scholar]
  52. Zhu F-C, Zhang J, Zhang X-F, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010 ; 376 : 895–902. [CrossRef] [PubMed] [Google Scholar]
  53. Zhang J, Zhang X-F, Huang S-J, et al. Long-term efficacy of a hepatitis E vaccine. N Engl J Med 2015 ; 372 : 914–22. [CrossRef] [PubMed] [Google Scholar]
  54. Zaman K, Julin CH, Aziz AB, et al. Safety and effectiveness of a recombinant hepatitis E vaccine in women of childbearing age in rural Bangladesh: a phase 4, double-blind, cluster-randomised, controlled trial. Lancet Glob Health 2024 ; 12 : e1288–99. [CrossRef] [PubMed] [Google Scholar]
  55. Nesbitt RC, Asilaza VK, Gignoux E, et al. Vaccination coverage and adverse events following a reactive vaccination campaign against hepatitis E in Bentiu displaced persons camp, South Sudan. PLoS Negl Trop Dis 2024 ; 18 : e0011661. [CrossRef] [PubMed] [Google Scholar]
  56. Aziz AB, Dudman S, Julin CH, et al. Receipt of hepatitis E vaccine and fetal loss in rural Bangladesh: further analysis of a double-blind, cluster- randomised, controlled trial. Lancet Glob Health 2024 ; 12 : e1300–11. [CrossRef] [PubMed] [Google Scholar]
  57. Nesbitt RC, Azman AS, Asilaza VK, et al. Safety of hepatitis E vaccine in pregnancy: an emulated target trial following a mass reactive vaccination campaign in Bentiu internally displaced persons camp, South Sudan. Lancet Glob Health 2024 ; 12 : e1881–90. [CrossRef] [PubMed] [Google Scholar]
  58. Lynch JA, Lim JK, Asaga PEP, et al. Hepatitis E vaccine—Illuminating the barriers to use. PLoS Negl Trop Dis 2023 ; 17 : e0010969. [CrossRef] [PubMed] [Google Scholar]
  59. WHO Immunization, Vaccines and Biologicals (IVB) team. WHO position paper on hepatitis E vaccines - May 2015. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.